Page 150 - DUOKOPT BIBLIOBOOK

DUOKOPT - bibliography book - CONFIDENTIAL - document for exclusive use by personnel of Laboratoires Théa – DO NOT DISTRIBUTE
®

Acta Ophthalmologica 2010

Glaucoma Trial Group (2003): Factors for field damage in patients with normal-tension bonic anhydrase inhibitor for primary
glaucoma progression and the effect of glaucoma. Jpn J Ophthalmol 50: 38–43. open-angle glaucoma and ocular hyperten-
treatment (the Early Manifest Glaucoma Nouri-Mahdavi K, Hoffman D, Coleman sion Brinzolamide Primary Therapy Study
Trial). Arch Ophthalmol 121: 48–56. AL, Liu G, Li G, Gaasterland D, Caprioli Group. Am J Ophthalmol 126: 400–408.
Leske MC, Heijl A, Hyman L, Bengtsson B, J; Advanced Glaucoma Intervention Study Spry PGD, Sparrow JM, Diamond JP &
Dong L, Yang Z; EMGT Group (2007): (2004a): Predictive factors for glaucoma- Harris HS (2005): Risk factors for progres-
Predictors of longterm progression in the tous visual field progression in the sive visual field loss in primary open-angle
Early Manifest Glaucoma Trial. Ophthal- Advanced Glaucoma Intervention Study. glaucoma. Eye 19: 643–651.
mology 114: 1965–1972. Ophthalmology 111: 1627–1635. Stams T, Chen Y, Boriack-Sjodin PA et al.
Lieb WE, Cohen SM, Merton DA, Shields Nouri-Mahdavi K, Hoffman D, Gaasterland (1998). Structures of murine carbonic anhy-
JA, Mitchell DG & Goldberg BB (1991): D & Caprioli J (2004b): Prediction of drase IV and human carbonic anhydrase II
Colour Doppler imaging of the eye and visual field progression in glaucoma. Invest complexes with brinzolamide: molecular
orbit: technique and normal vascular anat- Ophthalmol Vis Sci 45: 4346–4351. basis of isoenzyme-drug discrimination.
omy. Arch Ophthalmol 109: 527–531. Nouri-Mahdavi K, Hoffman D, Ralli M & Protein Sci 7: 556–563.
March WF & Ochsner KI (2000): The long- Caprioli J (2007): Comparison of methods Stewart WC, Kolker AE, Sharpe ED, Day
term safety and efficacy of brinzolamide to predict visual field progression in glau- DG, Holmes KT, Leech JN, Johnson M &
1.0% (Azopt) in patients with primary open- coma. Arch Ophthalmol 129: 1176–1181. Cantrell JB (2000): Factors associated with
angle glaucoma or ocular hypertension. The Ornek K, Gullu R, Ogurel T & Ergin A longterm progression or stability in pri-
Brinzolamide Longterm Therapy Study (2008): Short-term effect of topical brinzo- mary open-angle glaucoma. Am J Ophthal-
Group. Am J Ophthalmol 129: 136–143. lamide on human central corneal thickness. mol 130: 274–279.
Martinez A & Sanchez M (2005): Predictive Eur J Ophthalmol 18: 338–340. Strahlman E, Tipping R, Vogel R & the
value of colour Doppler imaging in a pro- Ozturk F, Ermis SS & Inan UU (2007): Com- International Dorzolamide Study Group
spective study of visual field progression in parison of the ocular hypotensive effects of (1995). A double-masked, randomized
primary open-angle glaucoma. Acta Oph- bimatoprost and timolol–dorzolamide com- 1-year study comparing dorzolamide (Trus-
thalmol Scand 83: 716–723. bination in patients with elevated intraocu- opt), timolol, and betaxolol. Arch Ophthal-
Martinez A & Sanchez M (2006): A compari- lar pressure: a 6-month study. Acta mol 113: 1009–1016.
son of the effects of 0.005% latanoprost Ophthalmol Scand 85: 80–83. Sugrue MF (2000): Pharmacological and
and fixed combination dorzolamide ⁄ timolol Pillunat LE, Bo ¨ hm AG, Ko ¨ ller AU, Schmidt ocular hypotensive properties of topical
on retrobulbar haemodynamics in previ- KG, Klemm M & Richard G (1999): Effect carbonic anhydrase inhibitors. Prog Retin
ously untreated glaucoma patients. Curr of topical dorzolamide on optic nerve head Eye Res 19: 87–112.
Med Res Opin 22: 67–73. blood flow. Graefes Arch Clin Exp Oph- Vesti E, Johnson CA & Chauhan BC (2003):
Martinez A & Sanchez M (2007): Retrobulbar thalmol 237: 495–500. Comparison of different methods for detect-
haemodynamic effects of the latanoprost ⁄ Pourcelot L (1975): Indications de l’ultrasonog- ing glaucomatous visual field progression.
timolol and the dorzolamide ⁄ timolol fixed raphie Doppler dans l’etude des vaisseaux Invest Ophthalmol Vis Sci 44: 3873–3879.
combinations in newly diagnosed glaucoma peripheriques. Rev Prat 25: 4671–4680. Weinstock FJ (1973): Ophthalmic hazards of
patients. Int J Clin Pract 61(5): 815–821. Riva CE & Petrig BL (1995): Choroidal hypotensive drugs. JAMA 224: 1039.
Martinez A & Sanchez M (2008a): Effects of blood flow by laser Doppler flowmetry. Wirtitsch MG, Findl O, Kiss B, Petternel V,
dorzolamide 2% added to timolol maleate Opt Eng 34: 746–752. Heinzl H & Drexler W (2003): Short-term
0.5% on intraocular pressure, retrobulbar Satilmis M, Orgul S, Doubler B & Flammer effect of dorzolamide hydrochloride on cen-
blood flow, and progression of visual field J (2003): Rate of progression of glaucoma tral corneal thickness in humans with cornea
damage in patients with primary open- correlates with retrobulbar circulation and guttata. Arch Ophthalmol 121: 621–625.
angle glaucoma: a single-centre, 4-year, intraocular pressure. Am J Ophthalmol Wirtitsch MG, Findl O, Heinzl H & Drexler
open-label study. Clin Ther 30: 1120–1134. 135: 664–669. W (2007): Effect of dorzolamide hydro-
MartinezA &Sanchez M(2008b): Ocular haemo- Sato S, Hirooka K, Baba T, Yano I & Shiraga chloride on central corneal thickness in
dynamics in pseudoexfoliative and primary F (2008): Correlation between retinal nerve humans with cornea guttata. Arch Oph-
open-angle glaucoma. Eye 22(4): 515–520. fibre layer thickness and retinal sensitivity. thalmol 125(10): 1345–1350.
Martinez A & Sanchez M (2008c): Retrobulbar Acta Ophthalmol 86: 609–613. Wistrand PJ (2000): Carbonic anhydrase inhi-
haemodynamic parameters in pseudoexfoli- Schmetterer L, Lexer F, Graselli U, Findl O, bition in ophthalmology: carbonic anhyd-
ation syndrome and pseudoexfoliative glau- Eichler HG & Wolzt M (1996): The effect of rases in cornea, lens, retina and lacrimal
coma. Graefes Arch Clin Exp Ophthalmol different mixtures of O 2 and CO 2 on ocular gland. EXS 90: 413–424.
246: 1341–1349. fundus pulsations. Exp Eye Res 63: 351–355. Zeitz O, Galambos P, Weirmann A et al.
Martinez A, Gonzalez F, Capeans C, Perez R Sender S, Gros G, Waheed A, Hageman GS (2006): Glaucoma progression is associated
& Sanchez-Salorio M (1999): Dorzolamide & Sly WS (1994): Immunohistochemical with decreased blood flow velocities in the
effect on the ocular blood flow. Invest localization of carbonic anhydrase IV in short posterior ciliary artery. Br J Ophthal-
Ophthalmol Vis Sci 40: 1270–1275. capillaries of rat and human skeletal mus- mol 90: 1245–1248.
Mu ¨ skens RPHM, De Voogd S, Wolfs RC, cle. J Histochem Cytochem 42: 1229–1236.
Witteman JC, Hofman A, de Jong PT, Shall K & the Brinzolamide Primary Therapy
Stricker BH & Jansonius NM (2007): Study Group (2000): The efficacy and safety
Systemic antihypertensive medication and of brinzolamide 1% ophthalmic suspension Received on October 20th, 2008.
incident open-angle glaucoma. Ophthal- (Azopt) as a primary therapy in patients Accepted on February 14th, 2009.
mology 114: 2221–2226. with open-angle glaucoma or ocular hyper-
Nagelhus EA, Mathiisen TM, Bateman AC, tension. Surv Ophthalmol 44: 155–162. Correspondence:
Haug FM, Ottersen OP, Grubb JH, Siesky B, Harris A, Cantor LB et al. (2008): Antonio Martı´nez
Waheed A & Sly WS (2005): Carbonic A comparative study of the effects of c ⁄ o Rosalia de Castro, 80 5º C
anhydrase XIV is rich in specific membrane brinzolamide and dorzolamide on retinal 15895 Ames
domains of retinal pigment epithelium, oxygen saturation and ocular microcircula- La Corun ˜ a
Mu ¨ ller cells, and astrocytes. Proc Natl tion in patients with primary open-angle Spain
Acad Sci U S A 102: 8030–8035. glaucoma. Br J Ophthalmol 92: 500–504. Tel: +34 6461 78104
Nakagami T, Yamazaki Y & Hayamizu F (2006): Silver LH (1998): Clinical efficacy and safety Fax: +34 9819 51670
Prognostic factors for progression of visual of brinzolamide (Azopt), a new topical car- Email: tontxu_1999@yahoo.com

552
150